These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 1934966)
1. Crossmatch procedures used in organ transplantation. Gebel HM; Lebeck LK Clin Lab Med; 1991 Sep; 11(3):603-20. PubMed ID: 1934966 [TBL] [Abstract][Full Text] [Related]
2. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry. Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity. Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580 [TBL] [Abstract][Full Text] [Related]
4. Sensitization and sensitivity: defining the unsensitized patient. Gebel HM; Bray RA Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756 [TBL] [Abstract][Full Text] [Related]
5. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M Clin Transpl; 2007; ():219-26. PubMed ID: 18642453 [TBL] [Abstract][Full Text] [Related]
6. Clinical cytometry and progress in HLA antibody detection. Bray RA; Tarsitani C; Gebel HM; Lee JH Methods Cell Biol; 2011; 103():285-310. PubMed ID: 21722808 [TBL] [Abstract][Full Text] [Related]
7. Effect of donor cell type on complement-dependent cytotoxicity crossmatch outcome for patients immunized against HLA class-II antigens. Arnold ML; Ensminger SM; Doxiadis II; Spriewald BM Exp Clin Transplant; 2008 Mar; 6(1):1-6. PubMed ID: 18405238 [TBL] [Abstract][Full Text] [Related]
8. Effect of crossmatching on outcome in organ transplantation. Wang-Rodriguez J; Rearden A Crit Rev Clin Lab Sci; 1995; 32(4):345-76. PubMed ID: 7576157 [TBL] [Abstract][Full Text] [Related]
16. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases. Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594 [TBL] [Abstract][Full Text] [Related]
17. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch. Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518 [TBL] [Abstract][Full Text] [Related]
18. Flow cytometry PRA using lymphocyte pools from random donors. Won DI; Jung HD; Jung OJ; Huh S; Suh JS Cytometry B Clin Cytom; 2007 Jul; 72(4):256-64. PubMed ID: 17205570 [TBL] [Abstract][Full Text] [Related]
19. The crossmatch in renal transplantation. Evaluation of flow cytometry as a replacement for standard cytotoxicity. Scornik JC; Brunson ME; Schaub B; Howard RJ; Pfaff WW Transplantation; 1994 Feb; 57(4):621-5. PubMed ID: 8116050 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity and antibody binding by flow cytometry: a single assay to simultaneously assess two parameters. Saw CL; Bray RA; Gebel HM Cytometry B Clin Cytom; 2008 Sep; 74(5):287-94. PubMed ID: 18454488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]